Podcasts about chb

Functional movement disorders are a common clinical concern for neurologists. The principle of “rule-in” diagnosis, which involves demonstrating the difference between voluntary and automatic movement, can be carried through to explanation, triage, and evidence-based multidisciplinary rehabilitation therapy. In this episode, Gordon Smith, MD, FAAN speaks Jon Stone, PhD, MB, ChB, FRCP, an author of the article “Multidisciplinary Treatment for Functional Movement Disorder” in the Continuum® August 2025 Movement Disorders issue. Dr. Smith is a Continuum® Audio interviewer and a professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Stone is a consultant neurologist and honorary professor of neurology at the Centre for Clinical Brain Sciences at the University of Edinburgh in Edinburgh, United Kingdom. Additional Resources Read the article: Multidisciplinary Treatment for Functional Movement Disorder Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Guest: @jonstoneneuro Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. This exclusive Continuum Audio interview is available only to you, our subscribers. We hope you enjoy it. Thank you for listening. Dr Smith: Hello, this is Dr Gordon Smith. Today I've got the great pleasure of interviewing Dr Johnstone about his article on the multidisciplinary treatment for functional neurologic disorder, which he wrote with Dr Alan Carson. This article will appear in the August 2025 Continuum issue on movement disorders. I will say, Jon, that as a Continuum Audio interviewer, I usually take the interviews that come my way, and I'm happy about it. I learn something every time. They're all a lot of fun. But there have been two instances where I go out and actively seek to interview someone, and you are one of them. So, I'm super excited that they allowed me to talk with you today. For those of our listeners who understand or are familiar with FND, Dr Stone is a true luminary and a leader in this, both in clinical care and research. He's also a true humanist. And I have a bit of a bias here, but he was the first awardee of the Ted Burns Humanism in Neurology award, which is a real honor and reflective of your great work. So welcome to the podcast, Jon. Maybe you can introduce yourself to our audience. Dr Stone: Well, thank you so much, Gordon. It was such a pleasure to get that award, the Ted Burns Award, because Ted was such a great character. I think the spirit of his podcasts is seen in the spirit of these podcasts as well. So, I'm a neurologist in Edinburgh in Scotland. I'm from England originally. I'm very much a general neurologist still. I still work full-time. I do general neurology, acute neurology, and I do two FND clinics a week. I have a research group with Alan Carson, who you mentioned; a very clinical research group, and we've been doing that for about 25 years. Dr Smith: I really want to hear more about your clinical approach and how you run the clinic, but I wonder if it would be helpful for you to maybe provide a definition. What's the definition of a functional movement disorder? I mean, I think all of us see these patients, but it's actually nice to have a definition. Dr Stone: You know, that's one of the hardest things to do in any paper on FND. And I'm involved with the FND society, and we're trying to get together a definition. It's very hard to get an overarching definition. But from a movement disorder point of view, I think you're looking at a disorder where there is an impairment of voluntary movement, where you can demonstrate that there is an automatic movement, which is normal in the same movement. I mean, that's a very clumsy way of saying it. Ultimately, it's a disorder that's defined by the clinical features it has; a bit like saying, what is migraine? You know? Or, what is MS? You know, it's very hard to actually say that in a sentence. I think these are disorders of brain function at a very broad level, and particularly with FND disorders, of a sort of higher control of voluntary movement, I would say. Dr Smith: There's so many pearls in this article and others that you've written. One that I really like is that this isn't a diagnosis of exclusion, that this is an affirmative diagnosis that have clear diagnostic signs. And I wonder if you can talk a little bit about the diagnostic process, arriving at an FND diagnosis for a patient. Dr Stone: I think this is probably the most important sort of “switch-around” in the last fifteen, twenty years since I've been involved. It's not new information. You know, all of these diagnostic signs were well known in the 19th century; and in fact, many of them were described then as well. But they were kind of lost knowledge, so that by the time we got to the late nineties, this area---which was called conversion disorder then---it was written down. This is a diagnosis of exclusion that you make when you've ruled everything out. But in fact, we have lots of rule in signs, which I hope most listeners are familiar with. So, if you've got someone with a functional tremor, you would do a tremor entrainment test where you do rhythmic movements of your thumb and forefinger, ask the patient to copy them. It's very important that they copy you rather than make their own movements. And see if their tremor stops briefly, or perhaps entrains to the same rhythm that you're making, or perhaps they just can't make the movement. That might be one example. There's many examples for limb weakness and dystonia. There's a whole lot of stuff to learn there, basically, clinical skills. Dr Smith: You make a really interesting point early on in your article about the importance of the neurological assessment as part of the treatment of the patient. I wonder if you could talk to our listeners about that. Dr Stone: So, I think, you know, there's a perception that- certainly, there was a perception that that the neurologist is there to make a diagnosis. When I was training, the neurologist was there to tell the patient that they didn't have the kind of neurological problem and to go somewhere else. But in fact, that treatment process, when it goes well, I think begins from the moment you greet the patient in the waiting room, shake their hand, look at them. Things like asking the patient about all their symptoms, being the first doctor who's ever been interested in their, you know, horrendous exhaustion or their dizziness. You know, questions that many patients are aware that doctors often aren't very interested in. These are therapeutic opportunities, you know, as well as just taking the history that enable the patient to feel relaxed. They start thinking, oh, this person's actually interested in me. They're more likely to listen to what you've got to say if they get that feeling off you. So, I'd spend a lot of time going through physical symptoms. I go through time asking the patient what they do, and the patients will often tell you what they don't do. They say, I used to do this, I used to go running. Okay, you need to know that, but what do they actually do? Because that's such valuable information for their treatment plan. You know, they list a whole lot of TV shows that they really enjoy, they're probably not depressed. So that's kind of useful information. I also spend a lot of time talking to them about what they think is wrong. Be careful, that they can annoy patients, you know. Well, I've come to you because you're going to tell me what's wrong. But what sort of ideas had you had about what was wrong? I need to know so that I can deal with those ideas that you've had. Is there a particular reason that you're in my clinic today? Were you sent here? Was it your idea? Are there particular treatments that you think would really help you? These all set the scene for what's going to come later in terms of your explanation. And, more importantly, your triaging of the patient. Is this somebody where it's the right time to be embarking on treatment, which is a question we don't always ask yourself, I think. Dr Smith: That's a really great point and kind of segues to my next question, which is- you talked a little bit about this, right? Generally speaking, we have come up with this is a likely diagnosis earlier, midway through the encounter. And you talked a little bit about how to frame the encounter, knowing what's coming up. And then what's coming up is sharing with the patient our opinion. In your article, you point out this should be no different than telling someone they have Parkinson's disease, for instance. What pearls do you have and what pitfalls do you have in how to give the diagnosis? And, you know, a lot of us really weren't trained to do this. What's the right way, and what are the most common land mines that folks step on when they're trying to share this information with patients? Dr Stone: I've been thinking about this for a long time, and I've come to the conclusion that all we need to do with this disorder is stop being weird. What goes wrong? The main pitfall is that people think, oh God, this is FND, this is something a bit weird. It's in a different box to all of the other things and I have to do something weird. And people end up blurting out things like, well, your scan was normal or, you haven't got epilepsy or, you haven't got Parkinson's disease. That's not what you normally do. It's weird. What you normally do is you take a deep breath and you say, I'm sorry to tell you've got Parkinson's disease or, you have this type of dystonia. That's what you normally say. If you follow the normal- what goes wrong is that people don't follow the normal rules. The patient picks up on this. What's going on here? This doctor's telling me what I don't have and then they're starting to talk about some reason why I've got this, like stress, even though I don't- haven't been told what it is yet. You do the normal rules, give it a name, a name that you're comfortable with, preferably as specific as possible: functional tremor, functional dystonia. And then do what you normally do, which is explain to the patient why you think it's this. So, if someone's got Parkinson's, you say, I think you've got Parkinson's because I noticed that you're walking very slowly and you've got a tremor. And these are typical features of Parkinson. And so, you're talking about the features. This is where I think it's the most useful thing that you can do. And the thing that I do when it goes really well and it's gone badly somewhere else, the thing I probably do best, what was most useful, is showing the patient their signs. I don't know if you do that, Gordon, but it's maybe not something that we're used to doing. Dr Smith: Wait, maybe you can talk more about that, and maybe, perhaps, give an example? Talk about how that impacts treatment. I was really impressed about the approach to physical therapy, and treatment of patients really leverages the physical examination findings that we're all well-trained to look for. So maybe explore that a little bit. Dr Stone: Yeah, I think absolutely it does. And I think we've been evolving these thoughts over the last ten or fifteen years. But I started, you know, maybe about twenty years ago, started to show people their tremor entrainment tests. Or their Hoover sign, for example; if you don't know Hoover sign, weakness of hip extension, that comes back to normal when the person's flexing their normal leg, their normal hip. These are sort of diagnostic tricks that we had. Ahen I started writing articles about FND, various senior neurologists said to me, are you sure you should write this stuff down? Patients will find out. I wrote an article with Marc Edwards called “Trick or Treat in Neurology” about fifteen years ago to say that actually, although they're they might seem like tricks, there really are treats for patients because you're bringing the diagnosis into the clinic room. It's not about the normal scan. You can have FND and MS. It's not about the normal scan. It's about what you're seeing in front of you. If you show that patient, yes, you can't move your leg. The more you try, the worse it gets. I can see that. But look, lift up your other leg. Let me show you. Can you see now how strong your leg is? It's such a powerful way of communicating to the patient what's wrong with them diagnostically, giving them that confidence. What it's also doing is showing them the potential for improvement. It's giving them some hope, which they badly need. And, as we'll perhaps talk about, the physio treatment uses that as well because we have to use a different kind of physio for many forms of functional movement disorder, which relies on just glimpsing these little moments of normal function and promoting them, promoting the automatic movement, squashing down that abnormal pattern of voluntary movement that people have got with FND. Dr Smith: So, maybe we can talk about that now. You know, I've got a bunch of other questions to ask you about mechanism and stuff, but let's talk about the approach to physical therapy because it's such a good lead-in and I always worry that our physical therapists aren't knowledgeable about this. So, maybe some examples, you have some really great ones in the article. And then words of wisdom for us as we're engaging physical therapists who may not be familiar with FND, how to kind of build that competency and relationship with the therapist with whom you work. Dr Stone: Some of the stuff is the same. Some of the rehabilitation ideas are similar, thinking about boom and bust activity, which is very common in these patients, or grading activity. That's similar, but some of them are really different. So, if you have a patient with a stroke, the physiotherapist might be very used to getting that person to think and look at their leg to try and help them move, which is part of their rehabilitation. In FND, that makes things worse. That's what's happening in Hoover sign and tremor entrainment sign. Attention towards the limb is making it worse. But if the patient's on board with the diagnosis and understands it, they'll also see what you need to do, then, in the physio is actively use distraction in a very transparent way and say to the patient, look, I think if I get you to do that movement, and I'll film you, I think your movement's going to look better. Wouldn't that be great if we could demonstrate that? And the patient says, yeah, that would be great. We're kind of actively using distraction. We're doing things that would seem a bit strange for someone with other forms of movement disorder. So, the patients, for example, with functional gait disorders who you discover can jog quite well on a treadmill. In fact, that's another diagnostic test. Or they can walk backwards, or they can dance or pretend that they're ice skating, and they have much more fluid movements because their ice skating program in their brain is not corrupted, but their normal walking program is. So, can you then turn ice skating or jogging into normal walking? It's not that complicated, I think. The basic ideas are pretty simple, but it does require some creativity from whoever's doing the therapy because you have to use what the patient's into. So, if the patient used to be a dancer- we had a patient who was a, she was really into ballet dancing. Her ballet was great, but her walking was terrible. So, they used ballet to help her walk again. And that's incredibly satisfying for the therapist as well. So, if you have a therapist who's not sure, there are consensus recommendations. There are videos. One really good success often makes a therapist want to do that again and think, oh, that's interesting. I really helped that patient get better. Dr Smith: For a long time, this has been framed as a mental health issue, conversion disorder, and maybe we can talk a little bit about early life of trauma as a risk factor. But, you know, listening to you talk, it sounds like a brain network problem. Even the word “functional”, to me, it seems a little judgmental. I don't know if this is the best term, but is this really a network problem? Dr Stone: The word “functional”, for most neurologists, sounds judgmental because of what you associate it with. If you think about what the word actually is, it's- it does what it says on the tin. There's a disordered brain function. I mean, it's not a great word. It's the least worst term, in my view. And yes, of course it's a brain network problem, because what other organ is it going to be? You know, that's gone wrong? When software brains go wrong, they go wrong in networks. But I think we have to be careful not to swing that pendulum too far to the other side because the problem here, when we say asking the question, is this a mental health problem or a neurological one, we're just asking the wrong question. We're asking a question that makes no sense. However you try and answer that, you're going to get a stupid answer because the question doesn't make sense. We shouldn't have those categories. It's one organ. And what's so fascinating about FND---and I hope what can incite your sort of curiosity about it---is this disorder which defies this categorization. You see some patients with it, they say, oh, they've got a brain network disorder. Then you meet another patient who was sexually abused for five years by their uncle when they were nine, between nine and fourteen; they developed an incredibly strong dissociative threat response into that experience. They have crippling anxiety, PTSD, interpersonal problems, and their FND is sort of somehow a part of that; part of that experience that they've had. So, to ignore that or to deny or dismiss psychological, psychiatric aspects, is just as bad and just as much a mistake as to dismiss the kind of neurological aspects as well. Dr Smith: I wonder if this would be a good time to go back and talk a little bit about a concept that I found really interesting, and that is FND as a prodromal syndrome before a different neurological problem. So, for instance, FND prodromal to Parkinson's disease. Can you talk to us a little bit about that? I mean, obviously I was familiar with the fact that patients who have nonepileptic seizurelike events often have epileptic seizures, but the idea of FND ahead of Parkinson's was new to me. Dr Stone: So, this is definitely a thing that happens. It's interesting because previously, perhaps, if you saw someone who was referred with a functional tremor---this has happened to me and my colleagues. They send me some with a functional tremor. By the time I see them, it's obvious they've got Parkinson's because it's been a little gap. But it turns out that the diagnosis of functional tremor was wrong. It was just that they've developed that in the prodrome of Parkinson's disease. And if you think about it, it's what you'd expect, really, especially with Parkinson's disease. We know people develop anxiety in the prodrome of Parkinson's for ten, fifteen years before it's part of the prodrome. Anxiety is a very strong risk factor for FND, and they're already developing abnormalities in their brain predisposing them to tremor. So, you put those two things together, why wouldn't people get FND? It is interesting to think about how that's the opposite of seizures, because most people with comorbidity of functional seizures and epilepsy, 99% of the time the epilepsy came first. They had the experience of an epileptic seizure, which is frightening, which evokes strong threat response and has somehow then led to a recapitulation of that experience in a functional seizure. So yeah, it's really interesting how these disorders overlap. We're seeing something similar in early MS where, I think, there's a slight excess of functional symptoms; but as the disease progresses, they often become less, actually. Dr Smith: What is the prognosis with the types of physical therapy? And we haven't really talked about psychological therapy, but what's the success rate? And then what's the relapse rate or risk? Dr Stone: Well, it does depend who they're seeing, because I think---as you said---you're finding difficult to get people in your institution who you feel are comfortable with this. Well, that's a real problem. You know, you want your therapists to know about this condition, so that matters. But I think with a team with a multidisciplinary approach, which might include psychological therapy, physio, OT, I think the message is you can get really good outcomes. You don't want to oversell this to patients, because these treatments are not that good yet. You can get spectacular outcomes. And of course, people always show the videos of those. But in published studies, what you're seeing is that most studies of- case series of rehabilitation, people generally improve. And I think it's reasonable to say to a patient, that we have these treatments, there's a good chance it's going to help you. I can't guarantee it's going to help you. It's going to take a lot of work and this is something we have to do together. So, this is not something you're going to do to the patient, they're going to do it with you. Which is why it's so important to find out, hey, do they agree with you with the diagnosis? And check they do. And is it the right time? It's like when someone needs to lose weight or change any sort of behavior that they've just become ingrained. It's not easy to do. So, I don't know if that helps answer the question. Dr Smith: No, that's great. And you actually got right where I was wanting to go next, which is the idea of timing and acceptance. You brought this up earlier on, right? So, sometimes patients are excited and accepting of having an affirmative diagnosis, but sometimes there's some resistance. How do you manage the situation where you're making this diagnosis, but a patient's resistant to it? Maybe they're fixating on a different disease they think they have, or for whatever reason. How do you handle that in terms of initiating therapy of the overall diagnostic process? Dr Stone: We should, you know, respect people's rights to have whatever views they want about what's wrong with them. And I don't see my job as- I'm not there to change everyone's mind, but I think my job is to present the information to them in a kind of neutral way and say, look, here it is. This is what I think. My experience is, if you do that, most people are willing to listen. There are a few who are not, but most people are. And most of the time when it goes wrong, I have to say it's us and not the patients. But I think you do need to find out if they can have some hope. You can't do rehabilitation without hope, really. That's what you're looking for. I sometimes say to patients, where are you at with this? You know, I know this is a really hard thing to get your head around, you've never heard of it before. It's your own brain going wrong. I know that's weird. How much do you agree with it on a scale of naught to ten? Are you ten like completely agreeing, zero definitely don't? I might say, are you about a three? You know, just to make it easy for them to say, no, I really don't agree with you. Patients are often reluctant to tell you exactly what they're thinking. So, make it easy for them to disagree and then see where they're at. If they're about seven, say, that's good. But you know, it'd be great if you were nine or ten because this is going to be hard. It's painful and difficult, and you need to know that you're not damaging your body. Those sort of conversations are helpful. And even more importantly, is it the right time? Because again, if you explore that with people, if a single mother with four kids and, you know, huge debts and- you know, it's going to be very difficult for them to engage with rehab. So, you have to be realistic about whether it's the right time, too; but keep that hope going regardless. Dr Smith: So, Jon, there's so many things I want to talk to you about, but maybe rather than let me drive it, let me ask you, what's the most important thing that our listeners need to know that I haven't asked you about? Dr Stone: Oh God. I think when people come and visit me, they sometimes, let's go and see this guy who does a lot of FND, and surely, it'll be so easy for him, you know? And I think some of the feedback I've had from visitors is, it's been helpful to watch, to see that it's difficult for me too. You know, this is quite hard work. Patients have lots of things to talk about. Often you don't have enough time to do it in. It's a complicated scenario that you're unravelling. So, it's okay if you find it difficult work. Personally, I think it's very rewarding work, and it's worth doing. It's worth spending the time. I think you only need to have a few patients where they've improved. And sometimes that encounter with the neurologist made a huge difference. Think about whether that is worth it. You know, if you do that with five patients and one or two of them have that amazing, really good response, well, that's probably worth it. It's worth getting out of bed in the morning. I think reflecting on, is this something you want to do and put time and effort into, is worthwhile because I recognize it is challenging at times, and that's okay. Dr Smith: That's a great number needed to treat, five or six. Dr Stone: Exactly. I think it's probably less than that, but… Dr Smith: You're being conservative. Dr Stone: I think deliberately pessimistic; but I think it's more like two or three, yeah. Dr Smith: Let me ask one other question. There's so much more for our listeners in the article. This should be required reading, in my opinion. I think that of most Continuum, but this, I really truly mean it. But I think you've probably inspired a lot of listeners, right? What's the next step? We have a general or comprehensive neurologist working in a community practice who's inspired and wants to engage in the proactive care of the FND patients they see. What's the next step or advice you have for them as they embark on this? It strikes me, like- and I think you said this in the article, it's hard work and it's hard to do by yourself. So, what's the advice for someone to kind of get started? Dr Stone: Yeah, find some friends pretty quick. Though, yeah, your own enthusiasm can take you a long way, you know, especially with we've got much better resources than we have. But it can only take you so far. It's really particularly important, I think, to find somebody, a psychiatrist or psychologist, you can share patients with and have help with. In Edinburgh, that's been very important. I've done all this work with the neuropsychiatrist, Alan Carson. It might be difficult to do that, but just find someone, send them an easy patient, talk to them, teach them some of this stuff about how to manage FND. It turns out it's not that different to what they're already doing. You know, the management of functional seizures, for example, is- or episodic functional movement disorders is very close to managing panic disorder in terms of the principles. If you know a bit about that, you can encourage people around you. And then therapists just love seeing these patients. So, yeah, you can build up slowly, but don't- try not to do it all on your own, I would say. There's a risk of burnout there. Dr Smith: Well, Dr Stone, thank you. You don't disappoint. This has really been a fantastic conversation. I really very much appreciate it. Dr Stone: That's great, Gordon. Thanks so much for your time, yeah. Dr Smith: Well, listeners, again, today I've had the great pleasure of interviewing Dr Jon Stone about his article on the multidisciplinary treatment for functional neurologic disorder, which he wrote with Dr Alan Carson. This article appears in the August 2025 Continuum issue on movement disorders. Please be sure to check out Continuum Audio episodes from this and other issues. And listeners, thank you once again for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. We hope you've enjoyed this subscriber-exclusive interview. Thank you for listening.

The Faculty Factory podcast is back this week with a deep exploration of academic promotions for clinicians as we interview Anne Walling, MB, ChB, who has written extensively about the topic. Her writings are based on her years of practical on-the-job experience with faculty. Dr. Walling is a professor emerita at the University of Kansas School of Medicine-Wichita in Wichita, Kansas and is the author of Academic Promotion for Clinicians: A Practical Guide to Promotion and Tenure in Medical Schools. She joins our show this week as a first-time guest to discuss the second edition of this book, along with exploring a variety of aspects related to promotions in academic medicine from many different angles. You can learn more about her book here: https://link.springer.com/book/10.1007/978-3-031-84036-4

As we are on hiatus, here's some of our Patreon bonus content for your listening pleasure! We finally did another CHB hypothetical for the bonus show! Send us an Iris message at oftheeldestgodspod@gmail.com with your thoughts and theories going forward! We would love to hear from you. Make sure to subscribe so you know when our next episode drops and rate and review if you like what we are doing. IG: ⁠⁠https://www.instagram.com/oftheeldestgodspod/⁠⁠ Twitter: ⁠⁠https://twitter.com/oftheeldestgods⁠⁠ Tumblr: ⁠⁠https://www.tumblr.com/oftheeldestgodspod⁠⁠ SUPPORT US ON PATREON: ⁠⁠https://www.patreon.com/oftheeldestgods⁠⁠ BUY OUR MERCH, PLZ:⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.redbubble.com/people/OfTheEldestGods/shop⁠⁠⁠⁠⁠ Charlie's IG: ⁠⁠https://www.instagram.com/greenpixie12/⁠⁠ and ⁠⁠https://www.instagram.com/greenpixiedraws/

BOO. Booby Traps For Senior Citizens. Welcome back to our Riordanverse readalong and analysis podcast!! Here's SZN17 Episode 2, where we discuss chapters 5-8(V-VIII) of Blood of Olympus. We're discussing Octavian's rise to power and his general audacity; we get lost in the favouritism of Camp Jupiter and its logistics compared to CHB; and in general we froth over Reyna's continuing amazingness because she's always been a full slay. We hope you'll join us next week for chapters 9-12 (IX-XII) of Blood of Olympus. xx Kate & Jo   Go and support our friend Fran (from The Best Dam Camp podcast) by reading their new book: ‘The Spiral of Life'!!! And leave a review on goodreads or Amazon! The Spiral of Life | Amazon ; The Spiral of Life | Goodreads   ::SOCIALS:: Follow us on Instagram: https://www.instagram.com/damsnackbarpod/ (@damsnackbarpod) Send us an IrisMessage to join our community. Email us at damsnackbarpod@outlook.com Consider donating to our ko-fi: https://ko-fi.com/damsnackbarpodcast All of our other social media is linked here: https://linktr.ee/damsnackbarpod Episode Guide: https://docs.google.com/document/d/1Ias3T7SOBIJe-_RDgau-po_7BQqJYS0aZbZ096BKk4g/edit?usp=sharing

In this episode, George Lau, MD, FRCP (Edin, Lond), FHKAM (Med), FHKCP, FAASLD, MBBS (HKU), and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Consequences to poor adherence to antiviral therapyStrategies to promote medication adherence (eg, patient education, setting up routines)The role of routine monitoring to prevent complications related to HBV such as hepatocellular carcinoma  Presenter: George Lau, MD, FRCP (Edin, Lond), FHKAM (Med), FHKCP, FAASLD, MBBS (HKU)Specialist in Gastroenterology & HepatologyChairman and Senior Consultant in Gastroenterology and HepatologyHumanity and Health Medical GroupHong Kong, ChinaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/49TuZ8UGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Dr. Tracey Lotze, MB.ChB, CCFPDr. Tracey Lotze graduated from medical school in South Africa in 2005. In 2008, she immigrated to Canada, where she has since practiced both Family and Emergency Medicine. Dr. Lotze has a special interest in women's health, particularly in sexual medicine and cosmetic gynecology.Over the years, Dr. Lotze has combined her extensive knowledge and experience to be part of a successful team at an urgent care clinic since 2013. She also holds an adjunct faculty position with the University of Northern British Columbia Medical Program, where she works with students and residents in the undergraduate medical program.Since 2015, Dr. Lotze has been a dedicated member of the Sexual Assault team for Northern BC. After years of service in emergency medicine, she retired from the UHNBC emergency medicine team in 2012.Currently, Dr. Lotze is enhancing her expertise in cosmetic gynecology and sexual health. She is passionate about creating a space that addresses sexual health, cosmetic gynecology procedures, and bioidentical hormone replacement therapy (BHRT) for both women and men.In her practice, Dr. Lotze integrates various aspects of sexual health, including hormone replacement, libido support, mental health support, and stress management, to help patients age with improved vitality. With certification from the Bader Medical Institute in London, she offers a range of cosmetic gynecology procedures such as labiaplasty, hoodectomy, vaginal tightening, labial filler, and procedures for both men and women, including the O-shot and P-shot.Dr. Lotze is dedicated to supporting her patients' physical, sexual, and mental health through comprehensive hormone replacement therapy and stress management techniques.

NBA Free Agency begun a little over twenty-four hours ago, the Cavs have hired Kenny Atkinson as there new head coach and drafted Jaylon Tyson with their 20th pick in the first round. Now what's next? Obviously, Donovan Mitchell, are there trades to be had? What's the deal with Jimmy Butler? Relly Hall and his special guest CHB from the land down under will get into it all on this episode of the “That's Rather Cavalier” podcast on FFSN. Learn more about your ad choices. Visit megaphone.fm/adchoices

Co-hosts Matt Nausid and Mike Napoletano sit down to recap Midwest Haunters Convention with Chicago Haunt Builders' very own Jim Slanker of Canyon Trail Cemetery. Jim & his wife, Dawn, help the CHB group connect with TransWorld & MHC to host shindigs, breakfasts, pop-up haunted houses on the show floor & even t-shirts! The boys got a chance to hear Emma Parker of Voodoo on Vassar's take on her first ever MHC weekend & thoughts going forward with haunting & haunt conventions. Mike also had the privilege of chatting with Kyle Miller (A.K.A. Doc from Baldwin Asylum). Kyle has been in the haunt industry since the Dream Reapers days & is in the process of resurrecting Baldwin Asylum while guest acting at Disturbia, Massacre, Evil on Erie during the MHC Pre-Convention Bus Tour on stilts, with a smoking head, a bionic arm, & forceps galore!

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:Engage key stakeholders in the provision of HBV care​Provide HBV management resources to support PCPs who are doing screening​Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters:Su Wang, MD, MPH, FACPMedical DirectorCenter for Asian Health and Viral Hepatitis ProgramsCooperman Barnabas Medical CenterRWJBarnabas-Rutgers Medical GroupAssociate MemberHealth Care Policy and Aging ResearchThe Rutgers Institute for HealthSenior AdvisorGlobal Health, Hepatitis B FoundationFlorham Park, New JerseyRichard R. Andrews, MD, MPHPresident, Houston Viral Hepatitis Task ForceFormer Co-Chair, National Task Force on Hepatitis BBoard-Certified Family MedicineAddiction Medicine PhysicianHouston, TexasRuth Brogden, MPHPatient AdvocateAmy S. Tang, MDFormer Co-Chair, National Task Force on Hepatitis BDirector of Immigrant HealthNorth East Medical ServicesSan Francisco, CaliforniaLink to full program: https://bit.ly/3TuqFHILink to the slides:https://bit.ly/44hXpHuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:Engage key stakeholders in the provision of HBV care​Provide HBV management resources to support PCPs who are doing screening​Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters:Su Wang, MD, MPH, FACPMedical DirectorCenter for Asian Health and Viral Hepatitis ProgramsCooperman Barnabas Medical CenterRWJBarnabas-Rutgers Medical GroupAssociate MemberHealth Care Policy and Aging ResearchThe Rutgers Institute for HealthSenior AdvisorGlobal Health, Hepatitis B FoundationFlorham Park, New JerseyRichard R. Andrews, MD, MPHPresident, Houston Viral Hepatitis Task ForceFormer Co-Chair, National Task Force on Hepatitis BBoard-Certified Family MedicineAddiction Medicine PhysicianHouston, TexasRuth Brogden, MPHPatient AdvocateAmy S. Tang, MDFormer Co-Chair, National Task Force on Hepatitis BDirector of Immigrant HealthNorth East Medical ServicesSan Francisco, CaliforniaLink to full program: https://bit.ly/3TuqFHILink to the slides:https://bit.ly/44hXpHuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:Engage key stakeholders in the provision of HBV care​Provide HBV management resources to support PCPs who are doing screening​Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters:Su Wang, MD, MPH, FACPMedical DirectorCenter for Asian Health and Viral Hepatitis ProgramsCooperman Barnabas Medical CenterRWJBarnabas-Rutgers Medical GroupAssociate MemberHealth Care Policy and Aging ResearchThe Rutgers Institute for HealthSenior AdvisorGlobal Health, Hepatitis B FoundationFlorham Park, New JerseyRichard R. Andrews, MD, MPHPresident, Houston Viral Hepatitis Task ForceFormer Co-Chair, National Task Force on Hepatitis BBoard-Certified Family MedicineAddiction Medicine PhysicianHouston, TexasRuth Brogden, MPHPatient AdvocateAmy S. Tang, MDFormer Co-Chair, National Task Force on Hepatitis BDirector of Immigrant HealthNorth East Medical ServicesSan Francisco, CaliforniaLink to full program: https://bit.ly/3TuqFHILink to the slides:https://bit.ly/44hXpHuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

MHC, CHB, HHC & more acronyms! Mike sits down with Kriz Zahrobsky of Haunted House Chicago to talk about Transworld, Midwest Haunters Convention, & the origins of traveling & reviewing haunts with Kris's company Haunted House Chicago. Matt Nausid of Greenbriar Cemetery jumps back on amidst baby-prepping to give this month's Haunter's Hack on height. Chicago Haunt Builder & Warden of Old Joliet Haunted Prison Adam Brandon Cygan joins the podcast to talk about working at the prison & also doing his home haunt walkthrough, Horror on Highland! It's a long episode, so strap in, but well worth the time to get you prepared for all the haunting events coming to the Chicagoland this summer!

I had the amazing opportunity to speak with some real life Camp Half Blood Directors and Counsellors about their lives at CHB. Did you know there's a real place for demigods? Check them out on Instagram, TikTok, and their shop too! To support the show, be sure to find us on Instagram and Twitter @bestdamcamppod and, if you can, join us on Patreon for early access and bonus content. If you'd like to get your thoughts across, you can email us at thebestdamcamp@hotmail.com. FREE PALESTINE: https://savepalestine.carrd.co Riordanverse Merchandise. Check out my Discord! Buy "Home to the Wild." Buy "Way of the Wild" Follow me on Goodreads. For more Percy Jackson content check out Fran's YouTube channel A Healthy Dose of Fran. Nickel Anarchy: Instagram and Redbubble Taylor Paisley-French: Instagram, Twitter, YouTube, and Spotify _________________________ Black Lives Matter links and resources: Ways to Help PLEASE SIGN PETITIONS, DONATE, CALL AND EMAIL TO DEMAND JUSTICE, AND SHARE Twitter Thread on how to support if you have no money Support for the Black Trans Community Twitter Thread for Black Creative Talent to support Advice on how to support from the UK 8 Lessons I Learned About Racism That Were Helpful to me a White Person Support Protestors Racism and the UK Stand With and Support the Asian community: Asian Lives Matter Resources Stand Against Hatred Stop AAPI Hate America's History of Scape-Goating its Asian citizens Support for the Trans community: How Black Trans People All About Trans Website Stonewall Website Support UK Mermaids Charity Native American Organisations: The Red Nation Stop Line 3 - Take Action Native Wellness Native American Rights Fund

No pod this week, but written report below, also enjoy one of our favourite pods:   Nick    Injury crisis - Taranto, Ross, Short - around 40% of salary cap injured (both quality and quantity, young, old and mid career players) Great start (again) Opposition string of unanswered goals (again) McAuliffe flashes Lefau showed power and some forward craft in air and on ground, tough match up, has big hands even for 195cm Dow - needed more Almost Jack 2010 levels of dependency on Shai Baker in very good form Young/Miller step back from last week Eagles young brigade damaging - Yeo, McGovern, Kelly, Duggan Wanted more from Brown and Campbell Nice to see Steely warm up with team as emergency as part of large WA contingency Loved Vlossy's hanger  VFL competitive but undermanned away vs good Werribee team (lacked any AFL listed onballers) Ryan v.good as fwd/ruck, Naismith dominating fwiw Kaleb Smith good without being dominant Glad for the bye   Andy    TT going out felt like one of the last foundational supports being lost, I was surprised that we were still relatively strong favourites at the bounce   The game was clearly lost in the midfield -23 in clearances, -7 in centre clearances and -21 in inside 50s. As discussed in the preview, WCE actually has a mature and talented midfield.  Injuries obviously a disaster: the entire starting midfield, both key forwards, CHB and in-game injury to short. All 5 of our last B&F winners.  Stat nerds like us generally believe that over the long run clubs have the same amount of injury 'luck', however, this year is testing the belief.  Judson injury after being sent back on with a obviously injured leg is a terrible look, whatever the truth of the matter.  Bye doesn't help that much, maybe Hopper and Grimes a possibility. Lynch's return date remains 10-12 weeks away.   On the game  -Pity they didn't end the game after the Flossy mark, we were up by 4 goals at the time.  -Nice game from Lefau, hard to calibrate the future of a 25 YO, 4th game key position player playing on a team getting smashed in the midfield. But good on him for taking his chance.  -Nank was dominate in the rucks but it was for naught . 13 CPs too. Having a career best year in tackles, clearances and CPs -Dow hopefully not fully fit, because he's struggling otherwise. -MJR another solid game, great goal. Disposal, tackle and goal stats all up this year.  -Young and Miller struggled, exposed by the midfield struggles.  -Tougher day at the office for Brown as well. Only 7 touches. Kaps may be in trouble. Kosi not taking his chance. However, to finish on a high note: Flossy leads the league in total intercepts, also going at 88% (!) for 22 disposals a game. The early AA talk is justified.       

This episode features Ewen M. Harrison, OBE, MB, ChB, MSc, PhD, a hepatobiliary and transplant surgeon from Edinburgh, Scotland, who gave the Distinguished Lecture of the International Society of Surgery at Clinical Congress 2023. In his lecture, “Artificial Intelligence and the Future of Global Surgery,” Dr. Harrison talks about using AI to enhance precision care through prediction and democratize surgical expertise, all while keeping in mind the ethical implications.   Talk about the podcast on social media using the hashtag #HouseofSurgery

Welcome back to another episode of Citizen Tacoma! Melissa Malott joins the podcast to discuss the health of Commencement Bay and what's threatening it. She gives an update on some of the industrial uses in the port and the work CHB is doing on that front. We get into the proposed rebuilding of the animal rendering plant and much more. She also speaks a little bit about the Tacoma Charter Review Committee and what's happening there. Enjoy! Links Melissa Malott at Communities for a Healthy Bay Tacoma Charter Review Channel 253 membership  

In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including:Current therapiesStudies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDFKaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis BEarly vs Late Postpartum Cessation of TDF Initiated for Prevention of Vertical HBV TransmissionInvestigational functional cure strategiesB-Together: Sequential Bepirovirsen and PegIFN Added to NA Therapy for Chronic HBV InfectionMARCH Part B: VIR-3434 ± VIR-2218 ± PegIFN Added to NA Therapy for Chronic HBV InfectionREEF-IT: JNJ-3989 + NA ± JNJ-6379 With PegIFN Add-on Consolidation in Patients With HBeAg-Positive CHBHBV003: VTP-300 + Nivolumab Added to NA Therapy for Chronic HBV InfectionCVP-NASVAC: Nasally Administered Therapeutic Vaccine for Chronic HBV InfectionPresenter:Nancy Reau, MDProfessor of MedicineRichard B. Capps Chair of HepatologyChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRush University Medical Center Chicago, IllinoisLink to full program: https://bit.ly/47XJlU4

In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including:Current therapiesStudies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDFKaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis BEarly vs Late Postpartum Cessation of TDF Initiated for Prevention of Vertical HBV TransmissionInvestigational functional cure strategiesB-Together: Sequential Bepirovirsen and PegIFN Added to NA Therapy for Chronic HBV InfectionMARCH Part B: VIR-3434 ± VIR-2218 ± PegIFN Added to NA Therapy for Chronic HBV InfectionREEF-IT: JNJ-3989 + NA ± JNJ-6379 With PegIFN Add-on Consolidation in Patients With HBeAg-Positive CHBHBV003: VTP-300 + Nivolumab Added to NA Therapy for Chronic HBV InfectionCVP-NASVAC: Nasally Administered Therapeutic Vaccine for Chronic HBV InfectionPresenter:Nancy Reau, MDProfessor of MedicineRichard B. Capps Chair of HepatologyChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRush University Medical Center Chicago, IllinoisLink to full program: https://bit.ly/47XJlU4

TAKE ACTION WITH DIANE KAZER & THE CHI TEAM —> JOIN MY VIP GROUP Only $7 for your first month: DianeKazer.com/VIP and get 50% off ALL Courses + 10% off ALL Supplements —> SHOP All Detox, Parasite Cleanse & Hormone Healing Supplements:  www.shop.dianekazer.com —> FREE Warrior Cleanse Module (also get on my email list): www.DianeKazer.com/FreeDetox —> Full Moon Parasite Cleanse FREE Module: www.DianeKazer.com/FMCFreeModule —> Book a call with Diane and the CHI Team: DianeKazer.com/call   FOLLOW DR DAVID NIXON'S WORK www.drdavidnixon.com   IN THIS SHOW, WE COVER: PFIZER C0Vid Shots - Proof of Borg technology & self assembling microorganisms Dental Anesthetics - are we at risk going to the dentist, especially the ones who are unaware of these toxic implications? BOTOX exposed - what Dr Nixon discovered under the microscope and what that means to your health What he found in other Injectables like Dupixent - prescriptions to ‘treat Eczema' which spiked post jabs (skin issues = parasite infections…this is what has been discovered under the miscope of the ‘shots') Are there any alternatives to these Injections? This is a bit of a heavy episode as we discuss truths that are not offered in the form of ‘Informed Consent' from the ‘professionals' in the Western Medicine community, so we are here to bring them to you and you can decide what to do from there. Dr David Nixon recently walked away from his medical practice of 25 years to pursue and disclose the truth of what is in these so called ‘vaxseens' and now has been on a mission to share what he's found in others such as Botox and other Western Medicine pharmaceuticals administered in IV form.   IN THIS EPISODE WE SHARE WHAT HE FOUND…   LINKS REFERENCED DURING THE SHOW: https://drdavidnixon.com//1/en/topic/about-me https://davidnixon.substack.com/p/comirnaty-sample-from-august-5th https://davidnixon.substack.com/p/comirnaty-sample-from-august-4th https://davidnixon.substack.com/p/comirnaty-sample-220802-as-seen-on https://davidnixon.substack.com/p/this-is-a-chip https://davidnixon.substack.com/p/construction-video-revised https://davidnixon.substack.com/p/borg-chip-2-re-visited https://davidnixon.substack.com/p/back-to-botox   FROM HIS WEBSITE: I graduated MB, ChB from the University of Otago in New Zealand in 1992. The purpose of this website is to share my observations and opinions with respect to the Covid-19 injectables. With respect to Colloidal Gold – trials haven't been conducted yet on people. The recent discussions are based on initial findings on a slide Clearly there has been a lot of things about the Covid-19 pandemic that hasn't made sense unless the events of the last three years are seen in a broader context and we consider other global agendas. It was never possible that we know that the Covid-19 injectables are safe in pregnancy, let alone effective and I am pleased to say that I actively always discouraged my pregnant patients not to have this medication. Clearly the official narrative was that these injectables were safe in pregnancy. As a medical professional I was constantly bombarded with this message from every official organization. And besides C0vid19 was such a threat during pregnancy that “you must have the vaccination” – really??? I became increasingly aware of the resounding unison of “there is nothing to see here” despite the number of groups and individuals who were posting concerning images online. So in mid 2022 I purchased a darkfield microscope and started looking at my own blood and that of patients. I also started looking at what we were injecting into people and I started voicing my concerns about what I was seeing.

**Scopri le differenze tra Chestnut Bud e White Chestnut nei Fiori di Bach! | Guida completa di Max Volpi** Ciao a tutti, sono Max Volpi, fondatore di ifioridibach.com e ideatore della Floriterapia Transpersonale Evolutiva®. Oggi esploriamo le sfumature di due potenti fiori di Bach: Chestnut Bud e White Chestnut. **Cosa sono i Fiori di Bach?** I Fiori di Bach sono rimedi floreali ideati da Edward Bach per affrontare le sfide emotive e mentali della vita. In questo video, approfondiremo due fiori chiave: Chestnut Bud e White Chestnut. **Origini comuni e differenze cruciali:** Entrambi provenienti dall'ippocastano Bianco, CHB e WHC hanno processi di estrazione unici. Chestnut Bud è ottenuto bollendo le gemme, mentre White Chestnut attraverso la solarizzazione dei fiori aperti. **Chestnut Bud: Impara dalle tue esperienze!** CHB è per coloro che ripetono gli stessi errori senza imparare. Max spiega come questo fiore aiuti a sviluppare consapevolezza e apprendimento dagli errori passati, promuovendo la crescita personale. **White Chestnut: Calma la mente dai pensieri ossessivi!** WHC è per chi lotta con pensieri ripetitivi e ossessivi. Scopri come questo fiore favorisce la chiarezza mentale e il rilassamento interiore, permettendoti di affrontare i problemi in modo sereno. **CHB e WHC: Come si sovrappongono e differiscono?** Max spiega come Chestnut Bud tratti errori inconsci, mentre White Chestnut affronta pensieri ripetitivi nella mente cosciente. La pianta è la stessa, ma i significati si sovrappongono parzialmente, creando una distinzione chiara. **Fiori di Bach non sono una bacchetta magica!** Max sottolinea che i Fiori di Bach preparano il terreno per il cambiamento, facilitando la comunicazione tra il sé superiore e la personalità. Il cambiamento personale è un processo graduale e non istantaneo. **Approfondimenti sulla Floriterapia Transpersonale Evolutiva:** Max invita a scoprire ulteriori dettagli sulla sua Floriterapia transpersonale evolutiva nel suo manuale di crescita personale con i Fiori di Bach, disponibile gratuitamente (pagando solo le spese di spedizione). **Conclusioni e prossimo video:** Grazie per essere stati con noi oggi! Se vuoi approfondire ulteriormente, assicurati di dare un'occhiata al mio manuale di crescita personale. Ci vediamo nel prossimo video! #FioriDiBach #ChestnutBud #WhiteChestnut #FloriterapiaTranspersonale #crescitapersonale ========== ➡ ARTICOLO SUL PENSIERO MAGICO INFANTILE https://ifioridibach.com/pensiero-magico-infantile-fiori-bach/ ✅ RISORSE Piccolo manuale di Crescita Personale con i Fiori di Bach: https://ifioridibach.com/manuale-crescita-fiori-di-bach/ Libro Trasforma il tuo Albero Genealogico con i Fiori di Bach: https://costellazionifloreali.com/offerta-riservata-libro/ ️ Webinar del mese: https://webinardelmese.com/ Scopri che relazione hai con tua madre: https://www.nonreggomiamadre.com/ Il tuo bambino interiore giace inascoltato? Scopri cosa fare: https://bambinointeriore.com/ ✅ CONTATTI Sito web: https://ifioridibach.com/ Community: https://www.facebook.com/groups/464138897285767 ️ Instagram: https://www.instagram.com/_ifioridibach_/

This important piece covers the recent Anestheia Patient Safety Foundation (APSF) conference on perioperative hemodynamic instability, and the recent recommendations that they have just launched. The Anestheia Patient Safety Foundation is here: https://www.apsf.org/ Presented by Desiree Chappell and Mike Grocott with their guests, Daniel Cole MD, APSF President, Louise Y. Sun MD, SM, FRCPC , FAHA Professor of Anesthesiology at Stanford University, Michael Scott MB, ChB, FRCP, FRCA, FFICM Professor of Anesthesiology at the University of Pennsylvania. -- Originally streamed live as part of our coverage of Anesthesiology 2023; the annual meeting of the American Society of Anesthesiologists (ASA), the largest and most important gathering of anesthesiologists in the world. We're your free front row seat. For more on the ASA go here: https://www.asahq.org/ Check out our YouTube page for a record of the live stream video of this podcast: https://www.youtube.com/@topmedtalk7687/streams

MOA. CHB's Mary-Jane Operation Is Now Swimming Under The Sea. Welcome back to our Riordanverse readalong and analysis podcast!! Here's SZN14 Episode 6, where we discuss chapters 21-24 (XXI-XIV) of Mark of Athena! Did somebody ask for a magic brownie? Well, courtesy of the seahorses that aren't seahorses, now you can have one! We're talking about what Shrimpzilla should have really been; Jo is insufferable with one New Girl reference (and Kate loses her mind); and Frank, Hazel, and Leo's little triangle just got a whole lot more complicated (it didn't actually, Rick just tried to make it seem that way). We hope you'll join us next week for chapters 25-28 (XXV-XXVIII) of Mark of Athena. xx Kate & Jo   GUEST ON THE PODCAST: DSB Heroes Collabs Form   ::SOCIALS:: Follow us on Instagram: https://www.instagram.com/damsnackbarpod/ (@damsnackbarpod) Send us an IrisMessage to join our community. Email us at damsnackbarpod@outlook.com Consider donating to our ko-fi: https://ko-fi.com/damsnackbarpodcast All of our other social media is linked here: https://linktr.ee/damsnackbarpod Episode Guide: https://docs.google.com/document/d/1Ias3T7SOBIJe-_RDgau- po_7BQqJYS0aZbZ096BKk4g/edit?usp=sharing

Clayton Hicklin and Kevin Amburgy join us for some absolutely amazing guitar and mandolin picking. Also a visit from Rob Lampe who joined the guys on Dobro for a couple tunes. Plus the usual rundown of events and your calls.CHB on FacebookClayton on Soundcloud

In this episode, Joseph Ahn, MD, MS, MBA; Christina Delacruz Leyson, MD; and Alice Chan, a person who experienced pregnancy as a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in people of childbearing potential and their infants, including:HBV screening and vaccination in pregnancyManagement of pregnant people who are HBsAg positiveInfant careBreastfeedingPresenters: Joseph Ahn, MD, MS, MBAProfessor of Medicine, Section ChiefDivision of Gastroenterology and HepatologyOregon Health & Science UniversityPortland, OregonChristina Delacruz Leyson, MDAssociate ProfessorMedical Director, Liver Transplant ProgramProgram Director, Hepatology FellowshipUniversity of KentuckyLexington, KentuckyAlice Chan, person living with chronic hepatitis BLink to downloadable slides:https://bit.ly/3rXLTC7Link to program: https://bit.ly/3L3Kz6l

Hear the extraordinary journey of a leading Trauma Consultant and how he struggled during his early life against all odds. Mr Ansar Mahmood shares life lessons that are applicable to all of us. Key topics covered in this episode:

WATCH: https://youtu.be/DU0M8D2bnSI Special thanks to Carlos Farias for allowing me to re-post this wonderful interview on Mind-Body Solution. Formerly named "The Truth", ‎"Sigma Series" seeks to better understand the fundamental nature of reality through philosophy, science, & art. His channel uncovers concepts from psychology, mythology, spirituality, literature, media, and more. If you like Mind-Body Solution, you'll love this educational channel. Please check it out and don't forget to subscribe! Tevin Naidu is a medical doctor, philosopher and ethicist. He attained his Bachelor of Medicine and Bachelor of Surgery (MB,ChB) degree from Stellenbosch University and his Master of Philosophy (MPhil) degree Cum Laude from the University of Pretoria. His academic work focuses on theories of consciousness, computational psychiatry, phenomenological psychopathology, values-based practice, moral luck, addiction, and the philosophy and ethics of science, mind and mental health. He is the former host of South Africa's most popular Asian lifestyle television shows – Eastern Mosaic and Mela. He is also well-known as a two-time castaway on the hit reality television show – Survivor South Africa, and as the host of Mind-Body Solution. EPISODE LINKS: - Carlos's Sigma Series: https://www.youtube.com/@SigmaCarlos - Original Interview: https://youtu.be/kMVrO-OpNFQ - ‎‎ @DrTonyNader 's Interview: https://youtu.be/T2_GAcVb8yE - Curt Jaimungal's ‎‎ @TheoriesofEverything recommendation of @MindBodySolution : https://youtu.be/eouxDJMlPuM CONNECT: - Website: https://tevinnaidu.com - Instagram: https://instagram.com/drtevinnaidu - Facebook: https://facebook.com/drtevinnaidu - Twitter: https://twitter.com/drtevinnaidu - LinkedIn: https://linkedin.com/in/drtevinnaidu TIMESTAMPS: (0:00) - Highlights (1:18) - Tevin's background (2:38) - Tevin's spiritual separation at age 9 (8:51) - Carlos's agency realization at age 9 (9:58) - The "pure ecstasy" of freedom (12:03) - Why did Tevin decide to become a doctor? (13:30) - Tevin describes the trials of medical school (16:40) - Crossing the threshold into television hosting (18:11) - Living a "double life" (20:00) - How did Tevin ultimately choose between medicine and TV media? (21:30) - The importance of context in media (24:44) - Tevin's castaway experiences on Survivor: South Africa (29:55) - What surprised Tevin most while playing Survivor? (32:18) - The pre-filming isolation chamber they don't tell you about (34:42) - Carlos's near brush with Survivor & 20 lbs gained (38:30) - Human sacrifices & forgiveness (second heaven) (42:10) - Turning down a job to play Survivor (44:32) - Seed of idea for Tevin's podcast (46:25) - What even is the truth? (47:08) - Tevin is ontologically agnostic, but knows certain things are not true (48:35) - Consider the optical window of earth (50:12) - Illusionism became interesting to Tevin (52:30) - 'Closer to Truth' already taken (54:54) - Carlos's rebrand idea to 'True Enough' (55:48) - Seekers of truth beware of existential nihilism (1:01:48) - Noam Chomsky not that interested in consciousness (1:04:52) - Why are we humans so obsessed with the mind-body problem? (1:07:50) - Perceptions and Bayesian processing (1:09:32) - Donald Hoffman and spacetime as doomed (1:20:54) - Neuroscientist Lisa Feldman Barrett and hierarchical Bayesian brains (1:24:17) - Tevin's thoughts on panpsychism (1:25:35) - "It's a weird world we live in..." (1:28:09) - Tevin's most surprising guest so far? (1:31:14) - Tevin's upcoming plans for his podcast? (1:36:16) - What's one piece of advice you'd given yourself while starting out? (1:37:13) - The time Tevin temporarily quit his podcast (1:44:03) - Creators usually fail (1:45:48) - Summary of Tevin's hero's journey Website · YouTube

In this episode, Stefan Zeuzem, MD, discusses new data on viral hepatitis presented at EASL 2023, including:Hepatitis B virusDurability of response with bepirovirsenHBsAg loss with siRNA VIR-2218 combined with either VIR-3434 (novel monoclonal antibody) or pegIFN-alfaHepatitis delta virus96-week follow-up of immediate vs delayed bulevirtideOff-treatment response for lonafarnib + ritonavir ± pegIFN-alfa Safety and efficacy outcomes with siRNA JNJ-3989 + nucleos(t)ide analogueHepatitis C virusCollaborative service at opiate substitution treatment clinic to improve linkage to care in IrelandNurse-led test-and-treat program to increase screening and diagnosis at female prisons in the United KingdomFIND-C study using machine learning to improve screening-to-diagnosis ratio using clinical factors and social determinants of healthPresenter:Stefan Zeuzem, MDProfessor of Medicine Chief, Department of Medicine JW Goethe University Hospital Frankfurt, GermanyLink to full program: https://bit.ly/3JQQj3J

In this episode, Robert S. Brown, Jr., MD, MPH; Nancy Reau, MD; and Eric, a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in older adults, including:Awareness of HBV and CHB in older adultsUpdated HBV screening and vaccination recommendationsMonitoring of renal and bone diseaseAdjustment of monitoring and treatment as a person with HBV agesPresenters: Robert S. Brown, Jr., MD, MPHVincent Astor Distinguished Professor of MedicineChief, Division of Gastroenterology and HepatologyWeill Cornell MedicineNew York, New YorkNancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisEric, person living with chronic hepatitis BLink to downloadable slides: please link to VM404 downloadable slides when readyLink to program: bit.ly/3L3Kz6l

In this episode, Essa Mohamed, PhD; Daouda Ndiaye; and Ponni Perumalswami, MD, MS, discuss strategies for overcoming barriers to HBV care in African immigrant people, including:HBV awareness and misconceptionsHBV-related stigmaLanguage barriersHealth insurance navigationPresenters:  Essa Mohamed, PhDClinical ResearcherDivision of Gastroenterology and HepatologyMayo ClinicRochester, MinnesotaDaouda NdiayePatient NavigatorPonni Perumalswami, MD, MSAssociate Professor of Internal MedicineDivision of Gastroenterology and HepatologyUniversity of MichiganAnn Arbor, MichiganLink to program: bit.ly/3L3Kz6l 

In this episode, Joseph Lim, MD; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and Jennifer Wild, MS, BSN, RN, OCN, discuss strategies for overcoming barriers to HBV care in Asian American people, including:HBV-related stigmaLanguage barriersHealth insurance navigationPresenters:Joseph Lim, MDProfessor of Medicine Director, Clinical HepatologyVice-Chief, Section of Digestive DiseasesYale University School of MedicineNew Haven, Connecticut Mindie H. Nguyen, MD, MAS, AGAF, FAASLDProfessor of Medicine (GI & Hepatology, Liver Transplant) Professor of Epidemiology & Population Health (By Courtesy)Director of Hepatology Fellowship Director of Hepatology ClerkshipStanford University Medical CenterPalo Alto, CaliforniaJennifer Wild, MS, BSN, RN, OCN Clinical NurseUCSF Helen Diller Family Comprehensive Cancer CenterGI Medical Oncology, Outpatient Hepatobiliary ProgramOakland, CaliforniaLink to downloadable slides: please link to VM401 downloadable slides when readyLink to program: please link to HEP 2023 HBV Key Communities VM (PRP5676) when ready

We are thrilled to have Dr. Stephen Kingsmore, a dedicated physician, researcher, an inventor, and who is the currently the President/CEO of Rady Children's Institute for Genomic Medicine in San Diego, California.  In this podcast, you will not only learn what drives Dr. Kingsmore's purpose to improve the lives of newborns and to prevent avoidable and unnecessary deaths due to late diagnosis of rare genetic condition, but also his challenges in clinical practice and research in making his dream of a learning healthcare system using genomic medicine a reality globally.  Among his achievements, Dr. Kingsmore pioneered the development of ultra-rapid Whole Genome Sequencing to decode rare disease in newborns. In 2021, he led the RCIGM team to break his own world speed record by achieving diagnosis via WGS in 13.5 hours. Dr. Kingsmore came to Rady Children's in 2015 from Children's Mercy Kansas City, where he was the Executive Director of Medical Panomics. He previously served as President and CEO of the National Center for Genome Resources; COO of Molecular Staging Inc.; Vice President of Research at CuraGen Corporation; founder of GatorGen; and Assistant Professor at the University of Florida's School of Medicine. Dr. Kingsmore received MB, ChB, BAO and DSc degrees from the Queen's University of Belfast. He trained in clinical immunology in Northern Ireland and did residency in internal medicine and fellowship at Duke University Medical Center. He is a fellow of the Royal College of Pathologists.  Learn from Dr. Kingsmore how to work through the challenges in research and clinical practice in advancing newborn screening research.   Podcast Interview Questions   Thank you, Dr. Kingsmore, for being a guest on the NBSTRN podcast, NBS SPOTlight. We are excited to speak with you today! Dr. Kingsmore, you are currently the President/CEO of Rady Children's Institute for Genomic Medicine, where you lead a multi-disciplinary team of scientists, physicians and researchers who are pioneering the use of rapid Whole Genome Sequencing to enable precise diagnoses for critically ill newborns. How did your interest in rare disease research lead you to San Diego? Many of us remember specific milestones you and your team have accomplished and your calls to action have inspired stakeholders across the NBS community. During your presentation at our NBS Research Summit in 2021 you spoke about “NBS and Rapid Whole Genome Sequencing (rWGS) for Severe Infant Onset Genetic Diseases". Most recently, you were a part of the International Conference on Newborn Sequencing (ICoNS) in augural meeting where you joined researchers from across the world to share information about newborn sequencing initiatives. What were the major takeaways from that meeting, and what should the NBS Research Community be aware of? You recently published that your team has developed a “Scalable, high quality, whole genome sequencing from archived, newborn, dried blood spots.” Up to eighty-one genetic diseases are included in screening, thirty-six of which are recommended for NBS by a federal advisory committee known as the Recommended Uniform Screening Panel. As you know, there are more than 7,000 rare genetic diseases (RD) that affect 6-8% of the US population or about 30 million Americans. Addition to the RUSP is a lengthy process.  What are your thoughts on how the use of genome sequencing using dried blood spots to identify rare diseases could change the landscape of newborn screening policy when we currently adopt one condition at a time and the nationwide implementation can take years? We appreciate your contribution to the American Journal of Medical Genetics Special Issue on Newborn Screening Research, where Dr. Amy Brower and Dr. Kee Chan were co-editors of this issue. Your article on the “Dispatches from Biotech beginning BeginNGS: Rapid newborn genome sequencing to end the diagnostic and therapeutic odyssey” highlights the BeginNGS, a consortium in collaboration with academia, pharmaceuticals, biotechnology and non-profit organization to provide a platform for implementing whole-genome sequencing for newborn screening, disease management and interventions, and rare disease drug development for use by partners around the world. Could you share the work in progress as of now? If we were to implement whole-genome sequencing for newborn screening globally one day, how do you envision long-term follow-up of management of care for the patient and families, including medical, non-medical, psychological services, education, and other related services to improve the quality of life to be supported? You received your medical training from the Queen's University of Belfast in Ireland. You trained in clinical immunology in Northern Ireland and did residency in internal medicine and fellowship at Duke University Medical Center. You are also a fellow of the Royal College of Pathologists. What sparked your interest in newborn screening? You have such a long history of successes and accomplishments that have global impact on health care and public health. In March of 2015, you surpassed your previous record in genetic sequencing by reducing the process to 26 hours, which was recognized in April 2016 by Guinness World Record as the fastest genetic sequencing in the world. Now, I think your team has reduced the time again.  On the flip side of the coin, would you mind sharing your biggest challenge —and what did you learn from that experience?  What's your biggest challenge in your research right now, and how are you tackling it? How could NBSTRN data tools and resources assist you? What does NBS research mean to you?

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That's the focus of this Special HBV Edition of eViralHepatitis Review.The first part of this program presented an evidence-based expert commentary by eViralHepatitis Review Program Director Dr. Mark Sulkowski — Professor of Medicine at Johns Hopkins and Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. This second part is an interview providing more in-depth discussions between Dr. Sulkowski and three of medicine's top CHB experts. Take our post-test to claim CME credits.To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.

Mike sits down with one of the core Chicago Haunt Builders, Shindig organizer & Canyon Trail Cemetery Home Haunt Owner, Jim Slanker. They discussed his roles in CHB, Transworld, Midwest Haunters Convention, the entire community & more. Plus, the Voodoo group (Mike, Matt and Emma) ventured to a Friday the 13th Slasher Night event in January at Basement of the Dead Haunted House in Aurora. The group recapped this & more to come in the future months within the Halloween world.

Ignacio Segovia is a CHB-certified hypnotist, coach, psychologist, lecturer, and author of Work-Life Balance Doesn't Work: How to achieve happiness and well-being in 5 steps. Passionate about helping individuals and organizations improve their well-being, Ignacio has spent over two decades studying the human mind and behavior. He holds a bachelor's degree in Psychology from the Central University of Venezuela and graduated from Paris Nanterre University with a master's in Industrial-Organizational Psychology and Ergonomics. Ignacio is also a Human-Centric Workplace Consultant and serves as the hypnotist and Brain Trainer of the Hypnosis Help Center. Ignacio joins me today to discuss work-life balance and why it no longer works. He describes his passion for programming the human mind and how it led him to pivot from engineering to psychology. He shares the key to creating a happy life and outlines the elements that lead people to achieve their goals. He also discusses the role of purpose and motivation in building habits and underscores why habits are essential to creating a beautiful, fulfilling life. Want more like this? Discover how to help more people and run a thriving hypnosis business at https://HypnoticBusinessSystems.com/ “When you facilitate hypnosis and use metaphors with clients, you create emotions which guide them to do the things that create the habits needed to have a beautiful life.” - Ignacio Segovia ●     Why Ignacio transitioned from studying engineering to psychology and how he discovered hypnosis●     Understanding the role of emotional states in building habits and creating a happy life●     World, Essence, Bonding, and the elements of building a fulfilled life●     The Kaizen methodology and the power of doing small things every day to achieve your goals●     Congruence and stepping into your identity●     Why “work/life balance” no longer works●     The five areas of life and how to evaluate them●     Why Ignacio is passionate about positive psychology, work-life balance, hypnosis, and coaching Resources Mentioned: ●     Book: 7 Habits of Highly Effective People by Stephen Covey Connect with Ignacio Segovia: ●     Hypnosis Help Center●     Work-Life Balance Doesn't Work●     Book: Work-Life Balance Doesn't Work: How to achieve happiness and well-being in 5 steps●     Work-Life Balance Doesn't Work on Facebook●     Ignacio Segovia on LinkedIn●     Ignacio Segovia on Instagram  Join our next online certification course… wherever you are in the world!●     https://WorkSmartHypnosisLIVE.com/  Get an all-access pass to Jason's digital library to help you grow your hypnosis business: ●     https://www.hypnoticbusinesssystems.com/ Get instant access to Jason Linett's entire hypnotherapeutic training library:●     https://www.hypnoticworkers.com/ If you enjoyed today's episode, please send us your valuable feedback! ●     https://www.worksmarthypnosis.com/itunes ●     https://www.facebook.com/worksmarthypnosis/ Join the new WORK SMART HYPNOSIS COMMUNITY on Facebook!●     https://www.facebook.com/groups/worksmarthypnosis/  Want to work with Jason? Check out:●     https://www.virginiahypnosis.com/call/ 

On today's show we discuss blood abnormalities in the vaccinated, including clumping of red blood cells, the ribbons of semi translucent material, the tube like structures and shard like entities. Constraints on live blood research. GUEST OVERVIEW: David Nixon graduated MB, ChB from the University of Otago in NZ in 1992. David has been a GP (family medicine doctor) for over 25 + years. Since retiring from Clinical Practice due to ongoing AHPRA restrictions and investigations of performance with respect to Covid management. David has published and lectured in Long Term Condition Management with a particular focus on Cardiovascular Risk Assessment and Population screening. David has been using a darkfield microscope to examine live blood for 6 months. He has had significant interaction with colleagues who have been performing live blood analysis for over 20 years. David is concerned about the abnormalities that have been seen in the blood for the last 18 months, some of which are also seen in the vaccine, and some which are associated with pathological states of the blood. David is keen to assist people to assess their own blood safely and affordably and is working on developing a population screening and management guideline.

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:Novel therapeutics for HBVHCV management strategiesHDV screening and linkage to careFatty liver disease in persons with viral hepatitisUse of statins to decrease morbidity and mortality in persons with liver diseasePresenter:Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate DirectorSolid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisLink to full program: https://bit.ly/3Y1tD6f

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:Hepatitis BPrevention of HBV vertical transmission when HBIg is unavailableTherapeutic vaccination for HBV cureAntiviral therapy to prevent HCC in patients with CHB in the indeterminate phaseHepatitis deltaHDV prevalence in ethnically diverse, urban, safety-net populationsBulevirtide ± pegIFN-α2a for chronic HDV in the French cATU studyBulevirtide monotherapy for patients with HDV and compensated cirrhosis in the HEP4Di studyHDV functional cure with lonafarnib-based therapyHepatitis CIntegrated community HCV service for PWUD: the ITTREAT studyHelios-3 study of treatment of people with HCV by specialists or nonspecialistsRisk of HCC after SVR in patients with HCVPresenter:Stefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine I JW Goethe University Hospital Frankfurt, GermanyFollow along with the downloadable slideset at: https://bit.ly/3FxIOwZLink to full program: https://bit.ly/3Y1tD6f

For supporting material on this podcast, visit: https://sleepreviewmag.com/sleep-disorders/hypersomnias/narcolepsy/narcolepsy-across-the-lifespan/Narcolepsy is a chronic sleep disorder for which there is no known cure. The onset of symptoms can begin at any age but frequently occurs during childhood or adolescence. This condition continues to impact patients throughout their lifetime. Management plans require implementation of ongoing pharmacological therapy to keep the symptoms under control for most patients, and patients may need substantial lifestyle adjustment such as maintaining nocturnal sleep hygiene and regular scheduling of daytime naps. Narcolepsy management plan development should consider balance between the tolerance to available medications and impact of certain comorbidities associated with the disorder.This episode is produced by Sleep Review. It is episode 1 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and NarcolepsyLink.com for more information.In episode 1, listen as Sleep Review's Sree Roy and neurologist-sleep specialist Michael Thorpy, MB, ChB, discuss: Since narcolepsy starts at a young age and there is no cure as of yet, what are the long-term management implications?What are the key symptoms of narcolepsy, and how and when do they typically manifest?Do narcolepsy symptoms evolve over the course of a lifetime?What can you typically accomplish with an individualized management plan?How often do you reassess narcolepsy patients to determine whether their management plan needs to be adjusted?Are there specific guidelines that you recommend to the physicians in the audience with regard to managing narcolepsy?

For supporting material on this podcast, visit: https://sleepreviewmag.com/sleep-disorders/hypersomnias/narcolepsy/narcolepsy-across-the-lifespan/Narcolepsy is a chronic sleep disorder for which there is no known cure. The onset of symptoms can begin at any age but frequently occurs during childhood or adolescence. This condition continues to impact patients throughout their lifetime. Management plans require implementation of ongoing pharmacological therapy to keep the symptoms under control for most patients, and patients may need substantial lifestyle adjustment such as maintaining nocturnal sleep hygiene and regular scheduling of daytime naps. Narcolepsy management plan development should consider balance between the tolerance to available medications and impact of certain comorbidities associated with the disorder.This episode is produced by Sleep Review. It is episode 1 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and NarcolepsyLink.com for more information.In episode 1, listen as Sleep Review's Sree Roy and neurologist-sleep specialist Michael Thorpy, MB, ChB, discuss: Since narcolepsy starts at a young age and there is no cure as of yet, what are the long-term management implications?What are the key symptoms of narcolepsy, and how and when do they typically manifest?Do narcolepsy symptoms evolve over the course of a lifetime?What can you typically accomplish with an individualized management plan?How often do you reassess narcolepsy patients to determine whether their management plan needs to be adjusted?Are there specific guidelines that you recommend to the physicians in the audience with regard to managing narcolepsy?

To celebrate beef month, Shane Bedwell visits with Bill Esch, Hen House, and Amari Seiferman, Certified Hereford Beef, to discuss the history of CHB on this episode of 1881. Tune in to hear a unique perspective on the brand and a look into the future.

"Curb Your Enthusiasm: Should Gabapentinoids Be a Routine Component of Multimodal Analgesia?" by Bassam Farhat, MD, Regional Anesthesia and Acute Pain Fellow, Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, Iowa; Vivian Ip, MB, ChB, FRCA, Associate Clinical Professor, Department of Anesthesia and Pain Medicine, University of Alberta, Edmonton, Alberta, Canada; and Rakesh V. Sondekoppam, MBBS, MD, Clinical Associate Professor, Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, Iowa.  From ASRA Pain Medicine News, May 2022. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.    

We all face difficulties and challenges through out our lives regardless of how different our circumstances may seem. On this weeks episode join me with the inspirational Wayne Forrest and be motivated to discover and embody what Wayne calls our “Inner warrior”!Wayne is an international transformational speaker and life mastery coach as well as a Ted x speaker. He's has shared the stage with many well known thought leaders such as Matt Boggs and international trainers and speakers such as my personal favorite Lisa Nichols. (Who you might know from the secret book & film!) Wayne had a sporting accident in 1995 that left him C5 tetraplegic and he said this was the catalyst for his ongoing personal development journey which has given him the incredible life he loves and is very grateful for. He is a co-creator of an award winning non for profit “CHB swim for lives” which supports local schools in deep water programs and swimming lessons to help save lives and prevent drowning. Wayne shares his journey from the heart to enable others to believe that YOU too can build and live your dreams, and live a life you love regardless of the challenges, struggles or perceived disabilities you face. Timestamps:4:55 - Wayne growing up on the farm14:51 - Wayne deciding to share his story17:40 - Advice on the craft of public speaking24:05 - Tapping in to your inner knowing34:05 - Sometime you have to say no38:57 - Stay curious--Let's Connect!To get more info and updates on the podcast@empoweredwithdeannaFollow my personal instagram account to connect with me!@fitdeannalolitaFor more information and to claim your FREE day by design sheet visit my website http://www.deannamerlinofit.com

"POCUS Spotlight: Lung Ultrasound," by William Manson, MD, Assistant Professor of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia; and Rosie Hogg, MB, ChB, FRCA, MD, Consultant Anaesthetist, Belfast Health & Social Care Trust, Belfast, United Kingdom. From ASRA Pain Medicine News, February 2022. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.   

In this episode, Jordan J. Feld, MD, MPH, and Nancy Reau, MD, share lessons learned in the testing and treatment of viral hepatitis in the COVID-19 era, including:Global impact of the COVID-19 pandemic on viral hepatitis testing and linkage to careImpact of COVID-19 pandemic on testing and treatment in the United States and CanadaInnovative strategies to improve linkage to care of patients with viral hepatitis during the COVID-19 pandemicPresenters:Jordan J. Feld, MD, MPHProfessor of MedicineUniversity of TorontoHepatologistToronto Centre for Liver DiseaseSandra Rotman Centre for Global HealthToronto, CanadaNancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisFollow along with the slides at:https://bit.ly/3HQ6dZ5Link to full program:https://bit.ly/3Bgyd5I

On today's episode Dooner and The Dude are talking about the latest supply chain impacts from the Ukrainian conflict; what war means for CHB; can autonomous fleets run 20 hours a day; Uber Freight's unique take on driver shortages; and trucking companies partner on driver health.With special guests Bill Driegert, head of operations and co-founder at Uber Freight; Tom Kroswek, vice president of strategy and business development at Locomation; Dr. Mark Manera, founder of The Trucking Fitness Co.; and Matt Haffner, vice president of customs brokerage at OEC Group.Visit our sponsorSubscribe to the WTT newsletterApple PodcastsSpotifyMore FreightWaves Podcasts

Shlomo Melmed, MD, MB, ChB, FRCP, MACP, is a Distinguished Professor of Medicine, Executive Vice-President and Dean of the Medical Faculty at Cedars-Sinai Medical Center and holds the Helene A. and Philip E. Hixon Chair in Investigative Medicine. Dr. Melmed completed his medical school from University of Cape Town and Residency in Internal Medicine from Sheba Medical Center in Israel. He then trained in Endocrinology at UCLA. His research focuses on molecular pathogenesis of pituitary tumors and pituitary receptor signaling. He has received Cedars-Sinai's ‘Pioneer in Medicine' Award and has also been honored with the Pituitary Society's ‘Lifetime Achievement' Award. He is editor-in-chief of The Pituitary, editor of Williams Textbook of Endocrinology and is on the editorial board of the Journal of Clinical Investigation. Dr. Melmed has been a faculty leader at Cedars-Sinai for nearly 40 years and has been the health system's chief academic officer since 1998. What is the difference between a good physician and a great physician? Dr. Melmed reflects on the culmination of his career in endocrinology and healthcare leadership to explore how tenacity, focus, and amelioration of patient anxiety continue to set the best practitioners apart from the rest in the ever-evolving field of medicine.  Join us to take advantage of the unique perspective offered by Dr. Melmed's unparalleled expertise and learn how “total commitment: physical, emotional and intellectual dedication” establishes the foundation of greatness and leadership. Pearls of Wisdom: 1. The patient's number one concern is not the disease or illness; it is anxiety. Our first job as the caretaker is to reassure them and comfort them, to tell them that everything will be okay and we are there for them. 2. The real sign of a great physician is their dedication and commitment. This amounts to being disciplined and strict with time when attending to the patient or interacting with colleagues. 3. Leadership goes beyond I, me, and myself. It is the ability of an individual to say yes when presented with opportunities and transform the people's mindset from ME to US.

BONUS. Demigod Diaries Pt1: Diary Of Luke Castellan. Welcome back to our Percy Jackson readalong and analysis podcast!! Here's SZN5 Episode 14, where we discuss The Diary of Luke Castellan from the Demigod Diaries. We hope you'll join us next week for The Lightning Thief Movie! xx Kate & Jo ::ADVERTISEMENTS:: Shop our merch!! https://www.redbubble.com/i/t-shirt/CHB-by-katemcdonnell99/13935956.6R8P0| https://www.teepublic.com/t-shirt/22543830-pod-logo ::SOCIALS:: Follow us on Instagram: https://www.instagram.com/damsnackbarpod/(@damsnackbarpod) Send us an IrisMessage to join our community. Email us at damsnackbarpod@outlook.com Consider donating to our ko-fi: https://ko-fi.com/damsnackbarpodcast All of our other social media is linked here: https://linktr.ee/damsnackbarpod Episode Guide: https://docs.google.com/document/d/1Ias3T7SOBIJe-_RDgau-po_7BQqJYS0aZbZ096BKk4g/edit?usp=sharing

TLO BONUS. "tragically straight". Welcome back to our Percy Jackson readalong and analysis podcast!! Here's SZN5 Episode 1, where we discuss that godawful statement that some intern made in that Pride Month Solangelo article. We also do the CHB vs CJ quiz. We hope you'll join us next week for Chapters 1-2 of The Last Olympian! xx Kate & Jo :::SOCIALS::: Follow us on Instagram: https://www.instagram.com/damsnackbarpod/(@damsnackbarpod) Send us an IrisMessage to join our community. Email us at damsnackbarpod@outlook.com Consider donating to our ko-fi: https://ko-fi.com/damsnackbarpodcast All of our other social media is linked here: https://linktr.ee/damsnackbarpod Episode Guide: https://docs.google.com/document/d/1Ias3T7SOBIJe-_RDgau-po_7BQqJYS0aZbZ096BKk4g/edit?usp=sharing

Join MitoAction and Dr. Madhu Davies from Reneo Pharmaceuticals for our February Monthly Mito Expert Series titled “Patients as Partners in Drug Development.” About the Speaker: Dr. Madhu Davies, MB, ChB, MRCG,P FFPM, MBA, is the medical director at Reneo Pharmaceuticals. Previously, Madhu has served many roles at companies developing medicines to patients with rare . For more than 25 years, she has provided leadership and advisory services working in clinical development, safety, regulatory programs, gaining broad experience of drug development including biologics, small molecules and vaccines. Madhu has held significant pharmaceutical roles as medical director and CMO, in addition to medical affairs. Madhu trained in medicine in the United Kingdom and maintains an active academic interest as Visiting Professor at Cardiff University; she is Director of the Postgraduate Course in Pharmaceutical Medicine and has also edited or contributed to several textbooks and journals.

On the podcast this week is Dr Jonathan Sackier, MB, ChB, FRCS, FACS who is an internationally renowned surgeon, technology innovator and entrepreneur. Trained in Britain as a surgeon and recruited to the USA in 1989 he helped lead the laparoscopic surgery revolution. As a Professor at George Washington University in Washington, DC, he founded, and funded the Washington Institute of Surgical Endoscopy, a center for education, research & innovation. He is a Visiting Professor of Medicine & Surgery at the University of Virginia and his activities in basic and clinical research funded by multiple grants have led to many publications, chapters and books. He has served multiple journals as editor or reviewer, has been involved in medical societies at the highest level and has been honored for his work in many countries. Jonathan's collaborations with the pharmaceutical and medical device industry have resulted in technologies that have been brought to market with partners like Valleylab, Pfizer, Karl Storz, Applied Medical and Pall. In 1984 his team at Genethics discovered and patented a line of amniotic stem cells and then licensed the rights to a publicly traded British drug discovery company. He helped develop and bring to market the AESOP robot with Computer Motion, who had a successful IPO in 1997 and has also started a medical products contract sales organization, a locum medical agency and a communications company. He has consulted to many companies including Aventis, Cook, Integra Neurosciences, Bayer, Cryocath, Novartis and ConvaTec and has worked with the financial community on enterprise financing, mergers & acquisitions and due diligence. A frequent commentator in the media, Jonathan has been a guest on radio and television many times to discuss various healthcare issues. In the mid-1990's he hosted a television health magazine program “Health and Wellness” aimed at a senior audience for the Goodlife Cable TV network and served the communications company Spotlight Health with their celebrity featured outreach including the hugely successful Carnie Wilson web-cast which drove increased attention to bariatric surgery as an option for the management of morbid obesity. Jonathan has served the National Committee of the Steppenwolf Foundation, is a Trustee of the First Star Foundation, the Virginia Hillel Board and previously chaired the Board of the Larry King Cardiac Foundation. He has sat on the Associate Board of AdvaMed (the medical device industry trade association) and on several corporate and scientific advisory boards.